Regarding “Long-term incidence of myocardial infarct, stroke, and mortality in patients operated on for abdominal aortic aneurysms”  by Kakisis, John D. et al.
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Regarding “Factors affecting career choice among the
next generation of academic vascular surgeons”
I was delighted to read your Web survey of residents and their
choice for a career in academic vascular surgery in America.1 This is
indeed one of the few studies examining the actual factors that
influence a young vascular surgeon’s choice in embarking on an
academic and educational career. There are similar parallels with
the career choices of young vascular surgeons in the United
Kingdom to those of your study.
In the United Kingdom, there is a new academic pathway
where, from a medical school perspective, students can embark on
an academic foundation program, which enables them throughout
their first and second years post-medical school to embark on an
academic theme throughout their training. They are then encour-
aged to apply for an academic clinical fellow job where they will
pursue a high degree such as a Doctorate in Medicine (MD) or a
Doctorate of Philosophy (PhD). Following on from this extended
period of 2 to 3 years of research and on embarking on a vascular or
general surgical rotation, they can then apply to become an aca-
demic clinical lecturer. The role of an academic clinical lecturer is
to practice and learn surgery 50% of the time and continue aca-
demic pursuits in the other 50%. This is for approximately 4 years,
and during this period, grants are attained to further the young
surgeons’ academic interests and projects as well as supervising
projects of BSc, PhD, and MD students.
The only limitation with this new run-through academic train-
ing is the fact that clinical training is reduced in comparison with a
nonacademic training. Also, the uncertainty of becoming a senior
lecturer at an institution is always there in the back of the mind.
However, embarking on these career pathways also offers some
stability because they are usually based in one particular unit in the
hospital, and, usually due to affiliations within the department, it is
likely that one will take up a permanent post in the department if
one is available.
I myself am interested in an academic vascular surgical career;
however, I am not entirely convinced of the quality and quantity of
clinical training in these posts. These posts appeared to be adopted
by a similar proportion of males and females. However, the num-
bers who wish to embark on an academic vascular surgical career
are small throughout the United Kingdom. With centralization of
services and reduced hours, we are finding clinical training more
and more extremely difficult. What do the authors feel about
embarking on a traditional surgical career and then having an
academic interest as many have done in the past?
i
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We appreciate the informative letter. There are indeed many
arriers to preparing for and succeeding in an academic career.
hile some such barriers are somewhat generic (ie, common to all
urgeons), others may be institution- and country-specific. Mech-
nisms to overcome these barriers are also likely to be both generic
nd institution- and country-specific. Our study examined what
re, in essence, generic factors important to vascular trainees when
eciding whether to choose a career in academic vascular surgery
nd suggests that young vascular surgeons entering the academic
rena desire mentorship, research and teaching opportunities, a
linically busy practice offering a variety of open and endovascular
rocedures, and the ability to work with like-minded individuals.
owever, the unfortunate reality is that, in the last decade,
edical institutions in the United States have placed more
mphasis on clinical productivity, as it generates funding for the
ospital and the medical school. This drive to increase clinical
ctivity has had the effect of making it more difficult for aca-
emic surgeons in the United States to also engage in and excel
n research and teaching activities.
Creating divergent pathways for academic and clinical training
s outlined in the letter is a potential solution to the pressures of
rying to excel in both academic and clinical endeavors, provided
oth tracks are equally valued within institutions. However, in our
pinion, for a surgeon, academic excellence should not come at the
xpense of clinical competence. Clinical competence is always
aramount. If the program outlined in the letter, combined with
ocal barriers to training, does not permit training of a clinically
ompetent and confident surgeon, the new paradigmwill either fail
r result in two classes of surgeons within the United Kingdom.
bviously, both are undesirable outcomes. Similar to the new 0/5
raining paradigm for vascular surgeons in the United States, the
nited Kingdom academic pathway will require careful ongoing
ssessment and re-evaluation. It is my hope that leaders in surgical
ducation worldwide remain keenly aware of the angst facing the
urgeon contemplating an academic career and engage young
eople in finding local solutions to common problems.
rica Leith Mitchell, MD
regon Health and Science University
ortland, Oregon
ttp://dx.doi.org/10.1016/j.jvs.2012.05.005
egarding “Long-term incidence of myocardial
nfarct, stroke, and mortality in patients operated on
or abdominal aortic aneurysms”
We have read with keen interest the article by Eldrup et al1 on
he long-term incidence ofmyocardial infarction, stroke, and death
n patients operated on for abdominal aortic aneurysm (AAA). The
tudy is based on an impressive series of 11,094 patients who
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September 2012898 Letters to the Editorunderwent open AAA repair and 44,376 age-matched and sex-
matched controls with up to 20 years of follow-up. The large
number of patients and the length of follow-up, as well as the
validity of the registries used in the study, guarantee the soundness
of the conclusion that AAA patients have a high risk of atheroscle-
rotic events and death.
However, as the authors rightfully remark, the data are limited
because the status of comorbidities was unknown. Whereas an
AAA patient is more likely to have a heavier atherosclerotic burden
than an age-matched and sex-matched control, this is not true for
every single AAA patient. Individualization of the risk is important
and may not be very difficult because there are several easy and
reliable tools to do so, including the ankle-brachial index (ABI)
and carotid ultrasound imaging.
In a study performed 10 years ago, we showed that the
presence of carotid stenosis 50% in patients undergoing elective
open AAA repair was an independent predictor of long-term death
from cardiovascular causes, associated with a 3.6-times increased
risk, whereas the presence of echolucent plaques increased the risk
by 3.8 times.2 An ABI 0.9 was also an independent predictor of
fatal cardiovascular events, associated with a 2.8-times increased
risk.
On the basis of these observations, we suggested that AAA
may be divided into two pathologic entities: one with AAA as a
local manifestation and one with AAA as part of generalized
atherosclerosis. The long-term course differs in these two
groups: AAA patients with substantial atherosclerosis are at
increased risk of cardiovascular events, whereas it is doubtful
whether AAA patients without other evidence of atherosclerosis
are at increased risk compared with age-matched and sex-
matched controls.
Although the best model that adequately fits the data is
sometimes cumbersome, relative risk computation in means of
estimating hazards ratios from proportional hazard models should
initially account for possible confounders in order to sufficiently
warrant adjustment for them in the analysis.3 In the study by
Eldrup et al,1 unadjusted hazard ratios might have led into misin-
terpretation of the results, because patients operated on for AAA
were not matched for known atherosclerotic factors to the general
population, with the exception of previous myocardial infarction
and stroke. Moreover, the inclusion of patients with advanced
atherosclerotic disease, such as the 351 patients operated on for
both peripheral occlusive disease and AAA, may destruct model
fitness and deteriorate the clinical appropriateness of the final
results.
Pooling data may be a feasible strategy to increase the size of
the effect estimate. However, misestimating might negatively af-
fect clinical decision making or policy development. Subgroup
analyses can give more unbiased estimates for specific populations
and might eventually provide clinicians more insight toward better
treatment of patients.
John D. Kakisis, MD
Constantine Antonopoulos, MD
Christos D. Liapis, MD
Department of Vascular Surgery
Athens University Medical School
“Attikon” University Hospital
Athens, Greece
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Thank you for the insightful response to our article. We fully
gree that the atherosclerotic burden in patients with aortic aneu-
ysm disease is probably not equal. Accordingly, we believe that
neurysm disease is a systemic tissue disorder rather than an ath-
rosclerotic manifestation.1 The two diseases do, however, share
any common risk factors, which perhaps explains the coincident
anifestation. It is important to note, however, that no study to
ate has proven that primary prevention in patients with an asymp-
omatic reduced ankle-brachial index will benefit from aspirin.2 It
s also becoming more apparent that in patients with asymptomatic
arotid plaques, the risk of major vascular events has been signifi-
antly reduced after the introduction of antithrombotics, statins,
nd increased antihypertensive medical treatment.3
In substance, we agree that the presence of a reduced ankle-
rachial index or a carotid plaque is associated with a higher
ardiovascular risk profile. However, no studies have tested
hether treatment in patients with abdominal aortic disease is not
eneficial in patients without these two disease markers. Recogniz-
ng that even after inclusion of the ankle-brachial index in risk
tratification models for otherwise healthy people, the discrimina-
ion only increases from 60% to 65% in men,4 with the conse-
uence of then incorrectly holding back prophylactic treatment in
p to 35% of the patients stratified.
This is also suggested in our data, where only marginal
hanges in risk of stroke, myocardial infarct, or all-cause mortality
re evidenced if all patients with previous stroke or myocardial
nfarct are taken out of the analysis.
Finally, we agree that the inclusion of the 356 patients treated for
eripheral occlusive disease and aneurysm at the same time could
otentially have biased the conclusions. With 2000 myocardial
nfarcts and 1000 strokes, however, it is unlikely that these 356
atients all should have an event and thereby render a false conclusion.
Until better models exist, we will still argue that all patients
ith an abdominal aortic aneurysm should receive treatment with
oth antithrombotics and statins.
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